✨ Health Notices




NEW ZEALAND GAZETTE, No. 48

15 MAY 2014


Health

Burial and Cremation Act 1964

Appointment of Manawatu District Council to Have the Control and Management of Rongotea Cemetery

Pursuant to section 23(3) of the Burial and Cremation Act 1964, His Excellency the Governor-General of New Zealand has appointed the Manawatu District Council to have the control and management of the Rongotea Cemetery, being 1.9879 hectares, more or less, being Lot 20A DP 514 and being the land contained in Identifier WN45/62 in the land registration district of Wellington, as from the date of signing.

Dated at Wellington this 30th day of April 2014.

HON TONY RYALL, Minister of Health.

go2840


Medicines Act 1981

Consent to the Distribution of a New Medicine

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicine which was referred to the Minister of Health under the provisions of section 24(5) of the Act and is set out in the Schedule hereto:

Schedule

Product: Arrow - Clopid
Active Ingredient: Clopidogrel bisulfate 97.875mg equivalent to Clopidogrel 75mg
Dosage Form: Film coated tablet
New Zealand Sponsor: Actavis New Zealand Limited
Manufacturer: Macleods Pharmaceuticals Limited, Himachal Pradesh, India

Dated this 8th day of May 2014.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

go2910


Suspension of Consent to the Distribution of Medicines

Pursuant to section 35(1)(b) of the Medicines Act 1981, the Minister of Health hereby suspends consent to the distribution in New Zealand of the following medicines for a period of one year from 15 May 2014:

Schedule

Product: Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 84.869mg equivalent to Venlafaxine 75mg
Dosage Form: Modified release capsule
New Zealand Sponsor: PSM Healthcare Limited trading as API Consumer Brands
Manufacturer: Wockhardt Limited, Maharashatra State, India

Product: Venlafaxine XR
Active Ingredient: Venlafaxine hydrochloride 169.738mg equivalent to Venlafaxine 150mg
Dosage Form: Modified release capsule
New Zealand Sponsor: PSM Healthcare Limited trading as API Consumer Brands
Manufacturer: Wockhardt Limited, Maharashatra State, India

Dated this 7th day of May 2014.

DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health (pursuant to delegation given by the Minister of Health on 11 September 2013).

go2911


Consent to the Distribution of New Medicines

Pursuant to section 20 of the Medicines Act 1981, the Minister of Health hereby consents to the distribution in New Zealand of the new medicines set out in the Schedule hereto:

Schedule

Product: 0.9% Sodium Chloride
Active Ingredient: Sodium chloride 9g/L
Dosage Form: Solution for infusion
New Zealand Sponsor: Baxter Healthcare Limited
Manufacturer: Baxter Healthcare Corporation, North Carolina, United States of America



Next Page →



Online Sources for this page:

Gazette.govt.nz PDF NZ Gazette 2014, No 48





✨ LLM interpretation of page content

πŸ₯ Appointment of Manawatu District Council to Manage Rongotea Cemetery

πŸ₯ Health & Social Welfare
30 April 2014
Cemetery, Control, Management, Rongotea, Manawatu District Council
  • HON TONY RYALL, Minister of Health

πŸ₯ Consent to Distribute New Medicine: Arrow - Clopid

πŸ₯ Health & Social Welfare
8 May 2014
Medicine, Distribution, Clopidogrel, Arrow - Clopid, Actavis New Zealand Limited
  • DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Suspension of Consent to Distribute Venlafaxine XR

πŸ₯ Health & Social Welfare
7 May 2014
Medicine, Suspension, Venlafaxine XR, PSM Healthcare Limited, Wockhardt Limited
  • DEREK FITZGERALD, Acting Group Manager, Medsafe, Ministry of Health

πŸ₯ Consent to Distribute New Medicine: 0.9% Sodium Chloride

πŸ₯ Health & Social Welfare
Medicine, Distribution, Sodium Chloride, Baxter Healthcare Limited